I agree with your take on additional financing. They will enroll approximately 500 patients in the frontline trial. That's less than I expected. By the time they begin this trial we will know more about 113. If they need more money to advance the pipeline - that's good news IMO.
Complete enrollment is expected to take 18 months but its going to take time to ramp up so let's say the half-way point is reached closer to 11 months. That would put the key interim analysis sometime right around June 2014....conveniently right before ASCO.